Screening tools for discovery of novel anabolic agents

Details Screening tools for discovery of novel anabolic agents Screening tools for discovery of novel anabolic agents

2006-01-12

2008-09-30

Nguyen, Quang (Department: 1633)

Chemistry: molecular biology and microbiology

Vector, per se

C435S455000, C536S024100

Reexamination Certificate

active

07429482

ABSTRACT:
The disclosure provides nucleic acids including the polynucleotide sequence of the human MAFbx core promoter involved in muscle specific expression. Also provided are reporters operably linked to a polynucleotide sequence including MAFbx transcription regulatory sequences, and constructs including polynucleotides that encode reporters and other polynucleotide sequences operably linked to the MAFbx core transcription regulatory sequence. Systems for identifying agents that inhibit muscle loss and/or increase muscle mass or tone are also provided.

REFERENCES:
patent: 6087164 (2000-07-01), Hochberg et al.
patent: 6645974 (2003-11-01), Hutchinson et al.
patent: 2002/0123456 (2002-09-01), Glass
patent: 2003/0077288 (2003-04-01), Goldberg et al.
patent: 2003/0129686 (2003-07-01), Glass et al.
patent: 2005/0265978 (2005-12-01), Chancellor et al.
patent: 2006/0069049 (2006-03-01), Goldberg et al.
Edstrom et al (Atrogin-1/MAFbx and MuRF1 Are Downregulated in Aging-Related Loss of Skeletal Muscle, Journal of Gerontology, 2006. 61A:663-674).
Frank et al (Clinical Biomarkers in Drug Discovery and Development, Nature Reviews, 2003. 2:566-580).
Wagner (Overview of biomarkers and surrogate endpoints in drug development, Disease Markers, 2002: 18:41-46).
Feng (Research Issues and Strategies for genomic and proteomic biomarker discovery and validation: a statisitical perspective, Future Medicine, 2004. 5(6):709-719).
Aarnisalo et al., “Transcription Activating and Repressing Functions of the Androgen Receptor Are Differentially Influenced by Mutations in the Deoxyribonucleic Acid-Binding Domain,”Endocrinology, 140(7):3097-3105, 1999.
Abu-Shakra et al., “Nerve stimulation and denervation induce differential patterns of immediate early gene mRNA expression in skeletal muscle,”Mol. Brain Res., 18(3):216-220, 1993.
Adler et al., “Multiple Components of a Complex Androgen-Dependent Enhancer,”Mol. Endocrinol., 5(11):1587-1596, 1991.
Altschul et al., “Gapped Blast and PSI-Blast: a new generation of protein database search programs,”Nucleic Acids Res., 25:3389-3402, 1977.
Angus et al., “Role of Intronic E- and N-box Motifs in the Transcriptional Induction of the Acetylcholinesterase Gene during Myogenic Differentiation,”J. Biol. Chem., 276(20):17603-17609, 2001.
Araki et al., “A Cluster of Four Sp1 Binding Sites Required for Efficient Expression of the Human Insulin Receptor Gene,”J. Biol. Chem., 266(6):3944-3948, 1991.
Bains et al., “Cardiac Actin Is the Major Actin Gene Product in Skeletal Muscle Cell Differentiation In Vitro,”Mol. Cell. Biol., 4(8):1449-1453, 1984.
Barbulescu et al., “New Androgen Response Elements in the Murine Pem Promoter Mediate Selective Transactivation,”Mol. Endocrinol., 15(10):1803-1816, 2001.
Batt et al., “Differential gene expression profiling of short and long term denervated muscle,”FASEB J., express article 10.1096/fj.04-3640fje. pp. 1-34, Epub Nov. 15, 2005.
Blagden et al., “Accelerated Response of themyogeninGene to Denervation in Mutant Mice Lacking Phosphorylation of Myogenin at Threonine 87,”Mol. Cell. Biol., 24(5):1983-1989, 2004.
Bodine et al., “Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy,”Science, 294(5547):1704-1708, 2001.
Catala et al., “A Skeletal Muscle-Specific Enhancer Regulated by Factors Binding to E and CArG Boxes is Present in the Promoter of the Mouse Myosin Light-Chain 1A Gene,”Mol. Cell. Biol., 15(8):4585-4596, 1995.
Cheng et al., “Oct-1 Is Involved in the Transcriptional Repression of the Gonadotropin-Releasing Hormone Receptor Gene,”Endocrinology, 143(12):4693-4701, 2002.
Clay et al., “Transcriptional Repression of the Glycoprotein Hormone α Subunit Gene by Androgen May Involve Direct Binding of Androgen Receptor to the Proximal Promoter,”J. Biol. Chem., 268(18):13556-13564, 1993.
Crabtree, Gerald R., “Generic Signals and Specific Outcomes: Signaling through Ca2+, Calcineurin, and NF-AT,”Cell, 96:611-614, 1999.
Dehoux et al., “Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection,”FEBS Letters, 544:214-217, 2003.
Dehoux et al., “Role of the Insulin-Like Growth Factor I Decline in the Induction of Atrogin-1/MAFbx during Fasting and Diabetes,”Endocrinology, 145(11):4806-4812, 2004.
Delany et al., “Transcriptional Repression of Insulin-Like Growth Factor I by Glucocorticoids in Rat Bone Cells,”Endocrinology, 136(11):4776-4781, 1995.
Delany et al., “Glucocorticoid Suppression of IGF I Transcription in Osteoblasts,”Mol. Endocrinol., 15(10):1781-1789, 2001.
Ferrando et al., “Testosterone administration to older men improves muscle function: molecular and physiological mechanisms,”Am. J. Physiol. Endocrinol. Metab., 282:E601-E607, 2002.
Furuno et al., “Role of Different Proteolytic Systems in the Degradation of Muscle Proteins during Denervation Atrophy,”J. Biol. Chem., 265(15):8550-8557, 1990.
Gayan-Ramirez et al., “Nandrolone decanoate does not enhance training effects but increases IGF-I mRNA in rat diaphragm,”J. Appl. Physiol., 88:26-34, 2000.
Gilley et al., “FOXO transcription factors directly activatebimgene expression and promote apoptosis in sympathetic neurons,”J. Cell Biol., 162(4):613-622, 2003.
Glass, David J., Molecular mechanisms modulating muscle mass,Trends in Molecular Medicine, 9(8):344-350, 2003.
Gomes et al., “Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy,”PNAS, 98(25):14440-14445, 2001.
Gregory et al., “Effects of testosterone replacement therapy on skeletal muscle after spinal cord injury,”Spinal Cord, 41(1):23-28, 2003.
Haddad et al., “Atrophy responses to muscle inactivity. II. Molecular markers of protein deficits,”J. Appl. Physiol., 95:791-802, 2003.
Hyatt et al., “Nerve activity-independent regulation of skeletal muscle atrophy: role of MyoD and myogenin in satellite cells and myonuclei,”Am J Physiol Cell Physiol, 285(5):C1161-C1173, 2003.
Janssen et al., “The Healthcare Costs of Sarcopenia in the United States,”JAGS, 52(1):80-85, 2004.
Kim et al, “Structure and Function of a Human Insulin-like Growth Factor-I Gene Promoter,”Mol. Endocrinol., 5(12):1964-1972, 1991.
Kostrominova et al., “Comparison of gene expression of 2-mo denervated, 2-mo stimulated-denervated, and control rat skeletal muscles,”Physiol. Genomics, 22(2):227-243, 2005.
Krempler and Brenig, “Zinc finger proteins: watchdogs in muscle development,”Mol. Gen. Genet., 261(2):209-215, 1999.
Latres et al., “Insulin-like Growth Factor-1 (IGF-1) Inversely Regulates Atrophy-induced Genes via the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (P13K/Akt/mTOR) Pathway,”J. of Biol. Chem., 280(4):2737-2744, 2005.
Lecker et al., “Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression,”FASEB J., 18:39-51, 2004.
Lee et al., “Regulation of Muscle Protein Degradation: Coordinated Control of Apoptotic and Ubiquitin-Proteasome Systems by Phosphatidylinositol 3 Kinase,”J. Am. Soc. Nephrol., 15:1537-1545, 2004.
Lewis et al., “Role of IGF-I and IGF-binding proteins within diaphragm muscle in modulating the effects of nandrolone,”Am. J. Physiol. Endocrinol. Metab., 282:E483-E490, 2002.
Li et al., “AKT-Independent Protection of Prostate Cancer Cells from Apoptosis Mediated through Complex Formation between the Androgen Receptor and FKHR,”Mol. Cell. Biol., 23(1):104-118, 2003.
Machida and Booth, “Changes in signalling molecule levels in 10-day hindlimb immobilized rat muscles,”Acta. Physiol. Scand., 183(2):171-179, 2005.
Magnusson et al., “Denervation-induced alterations in gene expression in mouse skeletal

Affiliated with

Also associated with

Rating

Screening tools for discovery of novel anabolic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Screening tools for discovery of novel anabolic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening tools for discovery of novel anabolic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3968274